| | Preventing Progression to Chronicity in First Onset, Subacute Low Back Pain: An Exploratory StudyAbstract Slater MA, Weickgenant AL, Greenberg MA, Wahlgren DR, Williams RA, Carter C, Patterson TL, Grant I, Garfin SR, Webster JS, Atkinson JH. Preventing progression to chronicity in first onset, subacute low back pain: an exploratory study. ObjectivesTo evaluate the effects of a behavioral medicine intervention, relative to an attention control, in preventing chronic pain and disability in patients with first-onset, subacute low back pain (LBP) with limitations in work-role function. DesignA 2-group, experimental design with randomization to behavioral medicine or attention control groups. SettingOrthopedic clinic at a Naval Medical Center. ParticipantsSixty-seven participants with first-onset LBP of 6 to 10 weeks of duration and impairment in work function, of whom 50 completed all 4 therapy sessions and follow-up 6 months after pain onset. InterventionFour 1-hour individual treatment sessions of either behavioral medicine, focused on back function and pain education, self-management training, graded activity increases, fear reduction, and pain belief change; or attention control condition, focused on empathy, support, and reassurance. Main Outcome MeasuresThe primary outcome was proportion of participants classified as recovered, according to pre-established clinical cutoffs on standardized measures, signifying absence of chronic pain and disability at 6 months after pain onset. Secondary analyses were conducted on pain, disability, health status, and functional work category. Intervention credibility and pain belief manipulation checks were also evaluated. ResultsChi square analyses comparing proportions recovered at 6 months after pain onset for behavioral medicine and attention control participants found relative rates of 52% versus 31% in the modified intent-to-treat sample (P=.09) and 54% versus 23% for those completing all 4 sessions and 6-month follow-up (P=.02). At 12 months, 79% of recovered and 68% of chronic pain participants still met criteria for their respective groups (P<.0001). Recovered participants also had higher rates of functional work status recovery at 12 months (recovered: 96% full duty and 4% light duty; chronic pain: 61% full duty, 18% light duty, and 21% medical discharge, respectively; P=.03). ConclusionsEarly intervention using a behavioral medicine rehabilitation approach may enhance recovery and reduce chronic pain and disability in patients with first-onset, subacute LBP. Effects are stronger for participants attending all 4 sessions and the follow-up assessment. List of Abbreviations: BMI, body mass index, DDS, descriptor differential scale, LBP, low back pain, PAIRS, pain and impairment relationship scale, QWB, quality of well-being, SIP, sickness impact profile a Department of Psychiatry, VA San Diego Healthcare System, San Diego, CA b Department of Psychology, VA San Diego Healthcare System, San Diego, CA c Department of Research, VA San Diego Healthcare System, San Diego, CA d Department of Surgery Services, VA San Diego Healthcare System, San Diego, CA e Department of Psychiatry, University of California San Diego, La Jolla, CA f Department of Orthopedic Surgery, University of California San Diego, La Jolla, CA g Department of Orthopedics, Naval Medical Center, San Diego, CA h Scottsdale Clinical Research Institute at Scottsdale Healthcare, Scottsdale, AZ Correspondence to Mark A. Slater, PhD, Vice President, Research, Scottsdale Clinical Research Institute at Scottsdale Healthcare, 10510 N. 92nd St, Ste 300, Scottsdale, AZ 85258
Supported by the Office of Research and Development, Health Services Research and Development Service and Medical Research Service, Department of Veterans Affairs (grant no. IIR-94-028). The opinions expressed are those of the authors and do not reflect the official policy or position of the Department of the Navy, the Department of Defense, or the United States Government. The voluntary informed consent of the subjects used in this research was obtained as required by SECNAVINST 3900.39B. The Chief, Bureau of Medicine and Surgery, Navy Department, Washington, DC, Clinical Investigation Program, sponsored this report, as required by HSETCINST 6000.41A. A commercial party having a direct financial interest in the results of the research supporting this article has conferred or will confer a financial benefit on 1 of the authors. Dr Atkinson is on the Scientific Advisory Board of Eli Lilly, which sells antidepressants, an alternative treatment method for low back pain. Reprints are not available from the author. PII: S0003-9993(09)00082-3 doi:10.1016/j.apmr.2008.10.032 Published by Elsevier Inc. | |
|